Hindustan Laboratories Limited, incorporated in 2017, is a pharmaceutical company focused on manufacturing and supplying generic medicines mainly to government institutions under a B2G model. The company works closely with central and state government agencies, supplying medicines across all major states and union territories in India. Its product portfolio is wide, covering various therapeutic areas like anti-diabetic, anti-infective, cardiac, respiratory, and nutritional supplements, with nearly 950 products as of September 2025. It has capabilities across multiple dosage forms such as tablets, capsules, syrups, and creams, supported by its manufacturing facility in Palghar, Maharashtra, which meets quality standards, while an additional unit is being set up for future expansion. With a growing customer base and strong presence in government healthcare supply, the company continues to scale its operations supported by a workforce of over 600 people including contract staff.